Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samira Bell

Showing results (51-60 of 105) with videos related to

Pageof 11
Sort By:
BMC Nephrology|June 12, 2026
"They are nae worrying about it… so …what's the point in asking?": A qualitative study of candidacy for early CKD care in areas of multiple deprivationBuse Keskindag, Tom Blakeman, Audrey Hughes, et al.
Diabetologia|December 7, 2019
Predicting renal disease progression in a large contemporary cohort with type 1 diabetes mellitusMarco Colombo, Stuart J McGurnaghan, Samira Bell, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 20, 2022
Demonstrating Benefit-Risk Profiles of Novel Therapeutic Strategies in Kidney Transplantation: Opportunities and Challenges of Real-World EvidenceIlkka Helanterä, Jon Snyder, Anders Åsberg, et al.
Journal of Nephrology|October 24, 2025
A European Delphi study on the management of anaemia of CKD: unmet needs in personalized treatmentIndranil Dasgupta, Roberto Minutolo, Samira Bell, et al.
Diabetologia|September 25, 2021
Diabetes status modifies the long-term effect of lipoprotein-associated phospholipase A2 on major coronary eventsMoneeza K Siddiqui, Gillian Smith, Pamela St Jean, et al.
The Journal of Infection|February 2, 2025
Immunocompromised individuals remain at risk of COVID-19: 2023 results from the observational INFORM studyJennifer K Quint, Sabada Dube, Lucy Carty, et al.
Diabetologia|January 10, 2020
Comparison of serum and urinary biomarker panels with albumin/creatinine ratio in the prediction of renal function decline in type 1 diabetesMarco Colombo, Stuart J McGurnaghan, Luke A K Blackbourn, et al.
Vaccines|January 24, 2025
Immunobridging Trials: An Important Tool to Protect Vulnerable and Immunocompromised Patients Against Evolving PathogensPedro Cruz, Jie Min Lam, Jehad Abdalla, et al.
Nature Reviews. Nephrology|December 5, 2025
The global epidemiology of acute kidney injury: challenges and opportunitiesJorge Cerda, Kianoush Kashani, Marlies Ostermann, et al.
The Lancet Regional Health. Europe|December 20, 2023
Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM studyRachael A Evans, Sabada Dube, Yi Lu, et al.
Pageof 11

Showing results (51-60 of 105) with videos related to

Sort By:
Pageof 11
BMC Nephrology|June 12, 2026
"They are nae worrying about it… so …what's the point in asking?": A qualitative study of candidacy for early CKD care in areas of multiple deprivationBuse Keskindag, Tom Blakeman, Audrey Hughes, et al.
Diabetologia|December 7, 2019
Predicting renal disease progression in a large contemporary cohort with type 1 diabetes mellitusMarco Colombo, Stuart J McGurnaghan, Samira Bell, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 20, 2022
Demonstrating Benefit-Risk Profiles of Novel Therapeutic Strategies in Kidney Transplantation: Opportunities and Challenges of Real-World EvidenceIlkka Helanterä, Jon Snyder, Anders Åsberg, et al.
Journal of Nephrology|October 24, 2025
A European Delphi study on the management of anaemia of CKD: unmet needs in personalized treatmentIndranil Dasgupta, Roberto Minutolo, Samira Bell, et al.
Diabetologia|September 25, 2021
Diabetes status modifies the long-term effect of lipoprotein-associated phospholipase A2 on major coronary eventsMoneeza K Siddiqui, Gillian Smith, Pamela St Jean, et al.
The Journal of Infection|February 2, 2025
Immunocompromised individuals remain at risk of COVID-19: 2023 results from the observational INFORM studyJennifer K Quint, Sabada Dube, Lucy Carty, et al.
Diabetologia|January 10, 2020
Comparison of serum and urinary biomarker panels with albumin/creatinine ratio in the prediction of renal function decline in type 1 diabetesMarco Colombo, Stuart J McGurnaghan, Luke A K Blackbourn, et al.
Vaccines|January 24, 2025
Immunobridging Trials: An Important Tool to Protect Vulnerable and Immunocompromised Patients Against Evolving PathogensPedro Cruz, Jie Min Lam, Jehad Abdalla, et al.
Nature Reviews. Nephrology|December 5, 2025
The global epidemiology of acute kidney injury: challenges and opportunitiesJorge Cerda, Kianoush Kashani, Marlies Ostermann, et al.
The Lancet Regional Health. Europe|December 20, 2023
Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM studyRachael A Evans, Sabada Dube, Yi Lu, et al.
Pageof 11